- Androgenetic alopecia, a hereditary form of hair loss affecting both men and women, is increasingly recognized as a significant dermatological condition driving demand for therapeutic and aesthetic interventions, including pharmacological treatments, hair restoration surgeries, and regenerative therapies across global markets
- The escalating demand for androgenetic alopecia treatments is primarily fueled by rising awareness of hair loss issues, greater acceptance of cosmetic procedures, and increasing use of over-the-counter and prescription solutions such as minoxidil and finasteride
- North America dominated the androgenetic alopecia market with the largest revenue share of 39% in 2024, attributed to higher healthcare expenditure, early adoption of advanced therapies, and a well-established cosmetic dermatology infrastructure, with the U.S. showing notable growth driven by direct-to-consumer telehealth platforms and personalized treatment approaches
- Asia-Pacific is expected to be the fastest growing region in the androgenetic alopecia market during the forecast period due to a growing aging population, increasing urbanization, and rising beauty consciousness among younger demographics
- The male segment dominated the androgenetic alopecia market with a market share of 61.8% in 2024, driven by a higher prevalence of hair loss in men and the wide availability of targeted treatment options catering specifically to male pattern baldness
